Breast cancers detected on MRI screens are most often invasive, study finds

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-09-26 14:30 GMT   |   Update On 2023-09-26 15:08 GMT

USA: A recent study published in Clinical Breast Cancer has found that MRI screen-detected breast cancers are most often invasive. Cancers detected by MRI screening were shown to have an excellent prognosis in the study population.Naveen Ghuman, Johns Hopkins University School of Medicine, Baltimore, MD, and colleagues revealed that these invasive screen-detected cancers are most...

Login or Register to read the full article

USA: A recent study published in Clinical Breast Cancer has found that MRI screen-detected breast cancers are most often invasive. Cancers detected by MRI screening were shown to have an excellent prognosis in the study population.

Naveen Ghuman, Johns Hopkins University School of Medicine, Baltimore, MD, and colleagues revealed that these invasive screen-detected cancers are most commonly presented as a mass.

Among 50 MRI screen-detected breast cancers in 47 women, the majority of cancers were invasive (64%). Most patients (91%) presented with stage 0 or 1 disease.

The American Cancer Society recommends annual supplemental breast screening with MRI for women having a greater than 20% lifetime risk for breast cancer. While there exists robust data regarding features of mammographic screen-detected breast cancers, the researchers note limited data regarding MRI-screen-detected cancers.

To fill this literature gap, Dr. Ghuman and the team described the clinical outcomes and imaging appearance of MRI screen-detected breast cancers. It included data from 50 screen-detected breast cancers in 47 women identified between 2016 and 2022.

The study led to the following findings:

  • The majority of MRI-screen-detected cancers (64%) were invasive.
  • Pathology revealed ductal carcinoma in situ (DCIS) in 36%, invasive ductal carcinoma (IDC) in 52%, invasive lobular carcinoma in 10%, and angiosarcoma in 2%.
  • The majority of patients (91%) were stage 0 or 1 at diagnosis and there were no breast cancer-related deaths during the follow-up periods.
  • Cancers presented as masses in 50%, non-mass enhancement in 48%, and a focus in 2%.
  • DCIS was more likely to present as non-mass enhancement (94.4%), whereas invasive cancers were more likely to present as masses (75%).
  • All cancers that were stage 2 at diagnosis were detected either on a baseline exam or more than 4 years after the prior MRI exam.

"The findings show that MRI screen-detected breast cancers were most often invasive cancers," the researchers wrote. "Cancers detected by MRI screening had an excellent prognosis in our study population."

Understanding the most common imaging presentations of MRI-screen-detected cancers may guide the interpretation and diagnostic performance of the exam," they concluded.

Reference:

The study titled, "Clinical and Imaging Features of MRI Screen-Detected Breast Cancer," was published online in Clinical Breast Cancer.

DOI: https://doi.org/10.1016/j.clbc.2023.09.012


Tags:    
Article Source : Clinical Breast Cancer

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News